Sociodemographic inequalities in sexual activity and cervical cancer screening: Implications for the success of human papillomavirus vaccination

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 4, 2013, Pages 641-652

  Drolet, Melanie ^a,b   Boily, Marie Claude ^a,g   Greenaway, Christina ^c,d   Deeks, Shelley L ^e,f   Blanchette, Caty ^a   Laprise, Jean Francois ^a   Brisson, Marc ^a,b,g  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c Division of Infectious Diseases   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e PUBLIC HEALTH ONTARIO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ABORIGINE; ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; CAUCASIAN; EDUCATIONAL STATUS; FEMALE; HEALTH CARE DISPARITY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SOCIAL STATUS; UTERINE CERVIX CANCER; VACCINATION;

ADULT; CANADA; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PROGNOSIS; PROSPECTIVE STUDIES; SEXUAL BEHAVIOR; SOCIAL CLASS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84876574486     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-1173     Document Type: Article

References (77)

1. Bray F, Loos AH, McCarron P, Weiderpass E, Arbyn M, Moller H, et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 2005;14:677-86. (Pubitemid 40489214)
2. Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ 2001;164:1017-25. (Pubitemid 34412231)
3. Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004;364: 249-56. (Pubitemid 38942814)
4. Parikh S, Brennan P, Boffetta P. Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer 2003;105:687-91. (Pubitemid 36687738)
5. Benard VB, Johnson CJ, Thompson TD, Roland KB, Lai SM, Cokkinides V, et al. Examining the association between socioeconomic status and potential human papillomavirus-associated cancers. Cancer 2008;113:2910-8.
6. Akers AY, Newmann SJ, Smith JS. Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States. Curr Probl Cancer 2007;31:157-81. (Pubitemid 46818418)
7. Newmann SJ, Garner EO. Social inequities along the cervical cancer continuum:a structuredreview.CancerCausesControl2005;16:63-70. (Pubitemid 40568852)
8. McDermott S, Desmeules M, Lewis R, Gold J, Payne J, Lafrance B, et al. Cancer incidence among canadian immigrants, 1980-1998: results from a national cohort study. J Immigr Minor Health 2011;13: 15-26.
9. Dupont MA, Pampalon R, Hamel D. Inegalites sociales et mortalite des femmes et des hommes atteints de cancer au Quebec, 1994-1998. Quebec, Canada: Institut National de Sante Publique duQuebec; 2004.
10. Howe HL,WuX, Ries LA, Cokkinides V, Ahmed F, Jemal A, et al. Annual report tothe nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 2006;107:1711-42. (Pubitemid 44582941)
11. Scarinci IC, Garcia FA, Kobetz E, Partridge EE, Brandt HM, Bell MC, et al. Cervical cancer prevention: new tools and old barriers. Cancer 2010;116:2531-42.
12. Leyden WA, Manos MM, Geiger AM, Weinmann S, Mouchawar J, Bischoff K, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst 2005;97:675-83. (Pubitemid 40812631)
13. Risendal B, DeZapien J, Fowler B, Papenfuss M, Giuliano A. Pap smear screening among urban Southwestern American Indian women. Prev Med 1999;29:510-8. (Pubitemid 30026546)
14. Peto J, Gilham C, Deacon J, Taylor C, Evans C, Binns W, et al. Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer 2004;91:942-53. (Pubitemid 39273789)
15. Yabroff KR, Lawrence WF, King JC, Mangan P, Washington KS, Yi B, et al. Geographic disparities in cervical cancer mortality: what are the roles of risk factor prevalence, screening, and use of recommended treatment? J Rural Health 2005;21:149-57. (Pubitemid 40463567)
16. BC Cancer Agency. Cervical cancer screening program 2009 annual report. Vancouver, BC, Canada: 2009 [accessed 2011 Jan 15th]. Available from: http://www.bccancer.bc.ca.
17. Owusu GA, Eve SB, Cready CM, Koelln K, Trevino F, Urrutia-Rojas X, et al. Race and ethnic disparities in cervical cancer screening in a safety-net system. Matern Child Health J 2005;9:285-95. (Pubitemid 43347882)
18. Blackwell DL, Martinez ME, Gentleman JF. Women's compliance with public health guidelines for mammograms and pap tests in Canada and the United States: an analysis of data from the Joint Canada/United States Survey Of Health. Womens Health Issues 2008;18:85-99.
19. Krzyzanowska MK, Barbera L, Elit L, Kwon J, Lofters AK, Saskin R, et al. Project for an Ontario Women's Health Evidence-based report (POWER) study. Vol. 1. Bierman AS, editor. Toronto, Canada, St. Michael's Hospital and Institute for Clinical Evaluative Sciences, 2009.
20. Lofters A, Glazier RH, Agha MM, Creatore MI, Moineddin R. Inadequacy of cervical cancer screening among urban recent immigrants: a population-based study of physician and laboratory claims in Toronto, Canada. Prev Med 2007;44:536-42. (Pubitemid 46817646)
21. McDonald JT, Kennedy S. Cervical cancer screening by immigrant and minority women in Canada. J Immigr Minor Health 2007;9:323-34. (Pubitemid 47248904)
22. Woltman KJ, Newbold KB. Immigrant women and cervical cancer screening uptake: a multilevel analysis. Can J Public Health 2007;98: 470-5.
23. Xiong H, Murphy M, Mathews M, Gadag V, Wang PP. Cervical cancer screening among Asian Canadian immigrant and nonimmigrant women. Am J Health Behav 2010;34:131-43.
24. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9. (Pubitemid 29406813)
25. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000;19:1-5.
26. Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol 2005;32(Suppl 1):S16-24. (Pubitemid 40332585)
27. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004;36:6-10. (Pubitemid 38258322)
28. Anderson RM, May RM. Infectious diseases of humans: dynamics and control: Oxford, United Kingdom: Oxford University Press; 1991.
29. Boily MC, Lowndes CM, Gregson S. Population-level risk factors for HIV transmission and 'the 4 Cities Study': temporal dynamics and the significance of sexual mixing patterns. AIDS 2002;16:2101-2. (Pubitemid 35205283)
30. Aral SO, Adimora AA, Fenton KA. Understanding and responding to disparities in HIV and other sexually transmitted infections in African Americans. Lancet 2008;372:337-40. (Pubitemid 352037427)
31. Kretzschmar M, Dietz K. The effect of pair formation and variable infectivity on the spread of an infection without recovery. Math Biosci 1998;148:83-113. (Pubitemid 28236902)
32. Morris M, Kurth AE, Hamilton DT, Moody J, Wakefield S. Concurrent partnerships and HIV prevalence disparities by race: linking science and public health practice. Am J Public Health 2009;99:1023-31.
33. Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001;285: 2995-3002. (Pubitemid 32550118)
34. Richardson H, Franco E, Pintos J, Bergeron J, Arella M, Tellier P. Determinants of low-risk and high-risk cervical human papillomavirus infections in Montreal University students. Sex Transm Dis 2000; 27:79-86. (Pubitemid 30082877)
35. Sellors JW, Karwalajtys TL, Kaczorowski J, Mahony JB, Lytwyn A, Chong S, et al. Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ 2003;168:421-5. (Pubitemid 36255727)
36. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003;157: 218-26. (Pubitemid 36152435)
37. Langille DB, Hughes J, Murphy GT, Rigby JA. Socio-economic factors and adolescent sexual activity and behaviour in Nova Scotia. Can J Public Health 2005;96:313-8. (Pubitemid 41226975)
38. Leichliter JS, Aral SO. Black women in the United States decrease their number of recent sex partners: temporal trends from the national survey of family growth. Sex Transm Dis 2009;36:1-3.
39. Laumann EO, Youm Y. Racial/ethnic group differences in the prevalence of sexually transmitted diseases in the United States: a network explanation. Sex Transm Dis 1999;26:250-61.
40. Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009;374:301-14.
41. Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007;356:1928-43. (Pubitemid 46740303)
42. Brisson M, Van de Velde N, Boily MC. Economic evaluation of human papillomavirus vaccination in developed countries. Public Health Genomics 2009;12:343-51.
43. Ministere de la sante et des services sociaux (MSSS). Surveillanceintervention: School-based vaccination coverage. Quebec surveillance report of intervention in infectious diseases 2010;5:1-2.
44. Colucci R, Hryniuk W, Savage C. HPV vaccination programs in Canada. Are we hitting the mark? Report card on cancer in Canada; 2011. [Accessed 2013 February 11th]. Available from: http://www. canceradvocacy.ca/reportcard/2008/ HPV%20Vaccination%20Programs% 20in%20Canada.pdf.
45. BC Centres for Disease Control. HPV dose 1 coverage 2010; 2012 [accessed 2012 Dec 20th]. Available from: http://www.bccdc.ca/NR/rdonlyres/3099C640-5E01- 415F-946B-6F0A02D8C644/0/HPVDose1PublicReport20110428. pdf.
46. Wilson S, Harris T, Stethi O, Fediurek J, Deeks SL. Vaccine coverage assessment for Ontario's school-based HPV vaccination program. In: Proceedings of the 10th Canadian Immunization Conference; 2012 Dec 3-5; Vancouver, Canada.
47. Statistics Canada. Canadian Community Health Survey (CCHS- Cycle 3.1-2005); 2011 [accessed 2011 Jan 15th]. Available from: www.statcan.gc.ca.
48. Drolet M, Brisson M, Maunsell E, Franco EL, Coutlee F, Ferenczy A, et al. The psychosocial impact of an abnormal cervical smear result. Psychooncology 2012;21:1071-81.
49. Statistics Canada. Canadian Community Health Survey (CCHS- Cycle 3.1-2005) Public use microdata file user guide; 2006. [Accessed 2013 February 11]. Available from: www.statcan.gc.ca.
50. Gouvernement du Quebec. Revolution tranquille 50 ans. Un courant d'inspiration; 2012 [accessed 2012 Sep 28th]. Available from: www. revolutiontranquille.gouv.qc.ca/.
51. Statistics Canada. Women in Canada: a gender-based statistical report 2011; 2012 [accessed 2012 Oct 2nd]. Available from: http://www5.statcan.gc.ca/ bsolc/olc-cel/olc-cel?catno1/489-503- XIE&lang1/4eng#formatdis.
52. Pigeon M. Education in Quebec, before and after the Parent reform 2010. Montreal, Canada: McCord Museum; 2012 [accessed 2012 Dec 20th]. Available from: http://wwwmccord-museumqcca/scripts/explorephp?Lang1/41&elementid1/ 4107-true&tableid1/411&tablename1/4 theme&contentlong.
53. Miller AB, Lindsay J, Hill GB. Mortality from cancer of the uterus in Canada and its relationship to screening for cancer of the cervix. Int J Cancer 1976;17:602-12.
54. Statistics Canada. Bootvar. Guide de l'usage (bootvar 3.2-version SAS) 2010; 2012 [accessed 2012 Sep 28th]. Available from: http://www.statcan.gc.ca/ rdc-cdr/data-donnee-fra.htm.
55. Lee WC. Characterizing exposure-disease association in human populations using the Lorenz curve and Gini index. Stat Med 1997;16: 729-39.
56. Carpenter J, Bithell J. Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat Med 2000;19: 1141-64. (Pubitemid 30265928)
57. DiCiccio T, Efron B. Bootstrap confidence intervals. Stat Sci 1996;11: 189-228. (Pubitemid 126706139)
58. Doescher MP, Jackson JE. Trends in cervical and breast cancer screening practices among women in rural and urban areas of the United States. J Public Health Manag Pract 2009;15: 200-9.
59. Langille DB, Asbridge M, Flowerdew G, Allen M. Associations of sexual risk-taking with having intercourse before 15 years in adolescent females in Cape Breton, Nova Scotia, Canada. Sex Health 2010;7: 199-204.
60. Greenberg J, Magder L, Aral S. Age at first coitus. A marker for risky sexual behavior in women. Sex Transm Dis 1992;19:331-4. (Pubitemid 23012464)
61. Sandfort TG, Orr M, Hirsch JS, Santelli J. Long-term health correlates of timing of sexual debut: results from a national US study.Am J Public Health 2008;98:155-61. (Pubitemid 351302610)
62. Ma Q, Ono-Kihara M, Cong L, Xu G, Pan X, Zamani S, et al. Early initiation of sexual activity: a risk factor for sexually transmitted diseases, HIV infection, and unwanted pregnancy among university students in China. BMC Public Health 2009;9:111.
63. Tota JE, Chevarie-Davis M, Richardson LA, Devries M, Franco EL. Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Prev Med 2011;53(Suppl 1):S12-21.
64. Sellors JW, Mahony JB, Kaczorowski J, Lytwyn A, Bangura H, Chong S, et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ 2000;163:503-8.
65. International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies. Cancer Epidemiol Biomarkers Prev 2009;18:1060-9.
66. Pottie K, Greenaway C, Feightner J, Welch V, Swinkels H, Rashid M, et al. Evidence-based clinical guidelines for immigrants and refugees. CMAJ 2011;183:E824-925.
67. Reading C, Wien F. Health inequalities and social determinants of aboriginal peoples' health. Prince George, Canada: National Collaborating Centre for Aboriginal Health; 2009.
68. Kraut-Becher J, Eisenberg M, Voytek C, Brown T, Metzger DS, Aral S. Examining racial disparities in HIV: lessons from sexually transmitted infections research. J Acquir Immune Defic Syndr 2008;47(Suppl 1): S20-7. (Pubitemid 351323597)
69. Young TK, Kliewer E, Blanchard J, Mayer T. Monitoring disease burden and preventive behavior with data linkage: cervical cancer among aboriginal people in Manitoba, Canada. Am J Public Health 2000; 90:1466-8.
70. Demers AA, Kliewer EV, Remes O, Onysko J, Dinner K, Wong T, et al. Cervical cancer among Aboriginal women in Canada. CMAJ 2012; 184:743-4.
71. Kliewer E, Elias B, Demers A, Lambert P, Hall M. HPV vaccine uptake among first nation people in Manitoba, Canada. In: Proceedings of the 27th International Human Papillomavirus Conference; 2011 Sep 17- 22; Berlin, Germany.
72. Smith LM, Brassard P, Kwong JC, Deeks SL, Ellis AK, Levesque LE. Factors associated with initiation and completion of the quadrivalent human papillomavirus vaccine series in an Ontario cohort of Grade 8 girls. BMC Public Health 2011;11:645.
73. Kliewer EV, Demers A, Lambert P, Brisson M. Disparities in Gardasil uptake in Manitoba, Canada prior to the implementation of an immunization program. In: Proceedings of the 26th International Papillomavirus Conference; 2010 July 3-8; Montreal, Canada.
74. Gariguet D. Early sexual intercourse. Health Reports 2005;16:9-18.
75. Fenton KA, Mercer CH, McManus S, Erens B, Wellings K, Macdowall W, et al. Ethnic variations in sexual behaviour in Great Britain and risk of sexually transmitted infections: a probability survey. Lancet 2005; 365:1246-55. (Pubitemid 40469657)
76. Wellings K, Collumbien M, Slaymaker E, Singh S, Hodges Z, Patel D, et al. Sexual behaviour in context: a global perspective. Lancet 2006; 368:1706-28. (Pubitemid 46055217)
77. The world Bank. Countries and Economies 2006; 2012 [accessed 2012 Sep 28th]. Available from: http://data.worldbank.org/country.